|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | |
| A61K 38/17 | |||
| A61K 38/19 | |||
| A61K 38/43 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 16/22 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2101807 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07869456.9 |
| Europos patento paraiškos padavimo data | 2007-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-09-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/088000 |
| Data | 2007-12-18 |
| (87) | Numeris | WO 2008/077077 |
| Data | 2008-06-26 |
| (30) | Numeris | Data | Šalis |
| 870741 P | 2006-12-19 | US | |
| 870745 P | 2006-12-19 | US | |
| 877267 P | 2006-12-27 | US | |
| 919638 P | 2007-03-22 | US | |
| 958384 P | 2007-07-05 | US | |
| 989397 P | 2007-11-20 | US |
| (72) |
FERRARA, Napoleone, US
KORSISAARI, Nina, US
MASS, Robert D., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (54) | VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS |
| VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS |